Research into precision medicine for Parkinson’s Disease patients based on repurposed drugs has received a $30 million research boost from the Medical Research Future Fund. The federal government says it is providing $30 million over five years to the Garvan Institute of Medical Research, Sydney, to trial ‘off label’ use of drugs such as salbutamol ...
Funding boost for Parkinson’s drug trials and nursing support
By Michael Woodhead
30 Jan 2019